• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

临床输血与检验 ›› 2026, Vol. 28 ›› Issue (5): 874-881.DOI: 10.3969/j.issn.1671-2587.2026.05.027

• 综述 • 上一篇    下一篇

红细胞程序性死亡机制及其病理生理意义研究进展*

陈麟凤1, 华宝来2   

  1. 1首都医科大学附属北京世纪坛医院输血科,北京 100038;
    2首都医科大学附属北京世纪坛医院血液科,北京 100038
  • 收稿日期:2026-09-03 修回日期:2026-09-23 出版日期:2026-10-20 发布日期:2026-11-11
  • 通讯作者: 华宝来,主要从事血液系统疾病、出血和血栓性疾病的诊疗方面研究,(E-mail)baolaihua@hotmail.com。
  • 作者简介:陈麟凤,主要从事临床输血、质控管理与单采治疗研究,(E-mail)pheonix9@126.com。
  • 基金资助:
    *本课题受国家自然科学基金面上项目(No.82070139)资助

Recent Advances in Mechanisms of Erythrocyte Programmed Death and Their Pathophysiological Significance

CHEN Linfeng1, HUA Baolai2   

  1. 1Department of Blood Transfusion Medicine, Beijing Shijitan Hospital Affiliated to Capital Medical University, Beijing 100038;
    2Department of Hematology, Beijing Shijitan Hospital Affiliated to Capital Medical University, Beijing 100038
  • Received:2026-09-03 Revised:2026-09-23 Online:2026-10-20 Published:2026-11-11

摘要: 红细胞程序性死亡是成熟红细胞在特定生理及病理刺激下主动发生的细胞死亡过程。与有核细胞凋亡不同,成熟红细胞缺乏细胞核及线粒体等经典凋亡执行结构,其死亡方式具有独特的分子特征和调控网络。目前已知的主要通路包括以磷脂酰丝氨酸外翻和细胞皱缩为标志的类凋亡通路(Eryptosis)、新近发现的裂解性程序死亡(Spectosis)以及铁死亡(Ferroptosis)和坏死性凋亡(Erythronecroptosis)等相关通路,各通路之间通过钙离子信号、氧化应激、鞘脂代谢及铁代谢等关键机制形成复杂的交互调控网络。红细胞程序性死亡的异常调控广泛参与多种疾病的病理过程,包括溶血性贫血、镰状细胞病、脓毒症、疟疾、慢性肾病及糖尿病等,其过度激活可导致红细胞过早清除和组织损伤,而调控不足则可能影响红细胞稳态。本文系统综述了红细胞程序性死亡的主要类型、分子调控机制及信号通路间的交叉作用,探讨其在各类疾病中的病理生理意义,旨在为靶向红细胞程序性死亡的诊断标志物开发及治疗干预策略提供理论依据和新思路。

关键词: 红细胞程序性死亡, 凋亡样程序性死亡, 裂解性程序死亡, 溶血性贫血, 慢性肾病

Abstract: Programmed death of red blood cells is an active cellular death process that occurs in mature erythrocytes under specific physiological and pathological stimuli. Unlike apoptosis in nucleated cells, mature erythrocytes lack the classic apoptotic execution structures such as a nucleus and mitochondria, and their death modes possess unique molecular features and regulatory networks. The currently known major pathways include the eryptosis pathway characterized by phosphatidylserine externalization and cell shrinkage, the newly discovered lytic programmed death Spectosis, as well as related pathways such as ferroptosis and erythronecroptosis. These pathways form a complex interactive regulatory network through key mechanisms including calcium signaling, oxidative stress, sphingolipid metabolism, and iron metabolism. Abnormal regulation of programmed erythrocyte death is widely involved in the pathological processes of various diseases, including hemolytic anemia, sickle cell disease, sepsis, malaria, chronic kidney disease, and diabetes. Its excessive activation can lead to premature clearance of red blood cells and tissue damage, while insufficient regulation may affect erythrocyte homeostasis. This article systematically reviews the main types of programmed erythrocyte death, molecular regulatory mechanisms, and cross-talk between signaling pathways, and explores their pathophysiological significance in various diseases, which could provide a theoretical basis and new ideas for the development of diagnostic markers and therapeutic intervention strategies targeting programmed erythrocyte death.

Key words: Programmed erythrocyte death, Eryptosis, Spectosis, Hemolytic anemia, Chronic kidney disease

中图分类号: